SeqOnce Biosciences is a biotechnology company specializing in the development of advanced Next Generation Sequencing (NGS) library preparation kits. The company serves researchers and diagnostic laboratories in the genomics market. SeqOnce's core products include the RhinoSeq and AzureSeq kits, which are designed to simplify and accelerate the process of preparing DNA and RNA samples for sequencing. These kits enable faster turnaround times and higher throughput, making them ideal for high-demand environments such as clinical diagnostics and large-scale genomic studies. SeqOnce generates revenue through the sale of these specialized kits, which are essential for efficient and accurate genomic analysis. The company operates on a B2B model, targeting institutions and organizations involved in genomic research and diagnostics.

Keywords: NGS, library prep, genomics, DNA sequencing, RNA sequencing, diagnostics, high-throughput, biotechnology, clinical research, genomic analysis.